# An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis

> **NCT06849778** · PHASE1 · COMPLETED · sponsor: **Taisho Pharmaceutical Co., Ltd.** · enrollment: 7 (actual)

## Conditions studied

- Patients on Hemodialysis

## Interventions

- **DRUG:** TS-172

## Key facts

- **NCT ID:** NCT06849778
- **Lead sponsor:** Taisho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-22
- **Primary completion:** 2025-04-24
- **Final completion:** 2025-04-24
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06849778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06849778, "An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06849778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*